224 related articles for article (PubMed ID: 23325627)
1. Soluble receptor for advanced glycation end products and risk of liver cancer.
Moy KA; Jiao L; Freedman ND; Weinstein SJ; Sinha R; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Hepatology; 2013 Jun; 57(6):2338-45. PubMed ID: 23325627
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
3. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.
Jiao L; Weinstein SJ; Albanes D; Taylor PR; Graubard BI; Virtamo J; Stolzenberg-Solomon RZ
Cancer Res; 2011 May; 71(10):3582-9. PubMed ID: 21540233
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
8. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
[TBL] [Abstract][Full Text] [Related]
9. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
10. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
11. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects.
Sebeková K; Krivošíková Z; Gajdoš M
Clin Chem Lab Med; 2014 Jan; 52(1):139-49. PubMed ID: 23509221
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.
Semba RD; Ferrucci L; Fink JC; Sun K; Beck J; Dalal M; Guralnik JM; Fried LP
Am J Kidney Dis; 2009 Jan; 53(1):51-8. PubMed ID: 18789567
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women.
Semba RD; Ferrucci L; Sun K; Patel KV; Guralnik JM; Fried LP
Age Ageing; 2009 May; 38(3):283-9. PubMed ID: 19252206
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
16. Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Borg DJ; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
Diabetes Care; 2015 Apr; 38(4):665-70. PubMed ID: 25573878
[TBL] [Abstract][Full Text] [Related]
17. Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.
Yu Y; Hanssen KF; Kalyanaraman V; Chirindel A; Jenkins AJ; Nankervis AJ; Torjesen PA; Scholz H; Henriksen T; Lorentzen B; Garg SK; Menard MK; Hammad SM; Scardo JA; Stanley JR; Wu M; Basu A; Aston CE; Lyons TJ
BJOG; 2012 Nov; 119(12):1512-20. PubMed ID: 22900949
[TBL] [Abstract][Full Text] [Related]
18. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
Grote VA; Nieters A; Kaaks R; Tjønneland A; Roswall N; Overvad K; Nielsen MR; Clavel-Chapelon F; Boutron-Ruault MC; Racine A; Teucher B; Lukanova A; Boeing H; Drogan D; Trichopoulou A; Trichopoulos D; Lagiou P; Palli D; Sieri S; Tumino R; Vineis P; Mattiello A; Argüelles Suárez MV; Duell EJ; Sánchez MJ; Dorronsoro M; Huerta Castaño JM; Barricarte A; Jeurnink SM; Peeters PH; Sund M; Ye W; Regner S; Lindkvist B; Khaw KT; Wareham N; Allen NE; Crowe FL; Fedirko V; Jenab M; Romaguera D; Siddiq A; Bueno-de-Mesquita HB; Rohrmann S
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):619-28. PubMed ID: 22301828
[TBL] [Abstract][Full Text] [Related]
19. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
